This site is devoted to copyright and issues of 'intellectual property,' particularly the issue's analytical aspects. It also concerns itself with the gap between public perception and the true facts, and with the significant lag time between the coverage on more technical sites and the mainstream press. For site feed, see: http://grafodexia.blogspot.com/atom.xml To see the list of sites monitored to create this site, see: http://rpc.bloglines.com/blogroll?html=1&id=CopyrightJournal
Thursday, October 25, 2007
Tuesday, October 16, 2007
Wednesday, October 10, 2007
Increasingly, I think the Open Access fight is being won, but the open data and open code fights are not even on the radar. There are examples to the contrary, but they are few and far between, at least in the basic sciences and public health.
Part of the problem is that privacy claims still have a veneer of legitimacy. Mind you, I think they're incredibly important, but they're becoming a catch-all excuse for hoarding. There need to be standards--both technical and behavioral--to ensure privacy. Maybe someone could even come up with a super-secure box, a server filled with hard drives that would be hardened against attack and could be used to store secure data, with all analyses requiring non-anonymized data being run before they leave the box. Want to do research on our data? Buy an ISOxxxx-compliant box and make sure the data never leaves it in non-anonymized form.
Tuesday, October 09, 2007
Sunday, October 07, 2007
Trackback for photos?
Wednesday, October 03, 2007
1) Bike parking. Want to pay for monthly secured parking in Harvard square? No problem. Want to pay to park your bike in the same garage below your building? Sorry, the rack's for residents only. Currently battling with this work after a year of happily parking my daily commuter indoors.
2) Pharmaceutical markets. Dr. Waldfogel mentions drugs as in the much-ballyhooed genomics revolution, but that's years off and going to be incredibly costly given current drug development costs. What we do know about drugs is that they are targeted towards the problems of the developed world, despite the vast majority of the world's disease burden residing elsewhere. We pour hundreds of millions into Anthrax, but virtually nothing into developing a Malaria vaccine.
Nothing much to say about the XO/OLPC, except that I held one before I left for Ghana and found it cute and well-designed. Given that they're building an infrastructure around it, I think they'll do just fine on their own merits.